Avalign Technologies, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Avalign Technologies, Inc. - overview

Established

1985

Location

-, IL, US

Primary Industry

Medical Devices & Equipment

About

Avalign Technologies, Inc. is a US-based firm specializing in the design and manufacturing of medical instrument cases and trays, providing innovative solutions tailored to healthcare providers and surgical facilities. Founded in 1985, Avalign Technologies, Inc. focuses on the production of custom and pre-made medical instrument cases and trays.


The company has undergone strategic developments and is headquartered in the US. In December 2018, Avalign was acquired by Linden Capital Partners for USD 309 mn. Jeffery McCaulley currently serves as the CEO. Avalign Technologies specializes in designing and manufacturing metal and thermoformed medical instrument cases and trays.


Their core offerings, which include customized and pre-made solutions, cater to various medical applications, emphasizing innovative versatility and quality. The products feature anodizing and nylon coating for improved functionality and digital anodizing for branding. These offerings are engineered for optimal sterilization processes, ensuring compliance with industry quality standards, catering to healthcare providers, surgical facilities, and medical device manufacturers across North America, Europe, and Asia. Operating primarily on a B2B model, Avalign Technologies generates revenue by supplying medical instrument cases and trays directly to hospitals, surgical centers, and medical device manufacturers.


Revenue is derived from direct sales and potential partnerships, with a product range that includes customized solutions for specific medical applications. Client-specific orders dictate pricing based on order complexity and volume, while the company's commitment to short lead times fosters repeat business and long-term client relationships. Following the acquisition in December 2018, Avalign Technologies aims to leverage the recent funding of USD 309 mn to enhance its product offerings and expand its market reach. The company is focused on launching new products tailored for evolving healthcare needs in North America, Europe, and Asia.


Specific geographic expansion plans are being developed, with targeted completion dates to be announced in upcoming strategic reviews.


Current Investors

Linden Capital Partners

Primary Industry

Medical Devices & Equipment

Sub Industries

Medical Equipment Distributors, Medical Supplies, Biomaterials

Website

www.advantismedical.com

Verticals

Manufacturing

Company Stage

Mature

Total Amount Raised

Subscriber access only

Avalign Technologies, Inc. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Add-onCompletedSlice Manufacturing Studios-
Secondary BuyoutCompletedAvalign Technologies, Inc.-
Add-onCompletedThortex America, Inc.-
Add-onCompletedMillennium Surgical-
Secondary BuyoutCompletedAvalign Technologies, Inc.-

Displaying 1 - 5 of 9

Avalign Technologies, Inc. - key contacts

NamePositionStart DateEnd DateVcardBio 
Member, Board of DirectorsBM

BM Board Member

Want to see more?

Request a demo for full access to this profile

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.